New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 15 states.
Cannabis sales decreased 0.3% sequentially in November, which was an increase on a per-day basis of 3.0%. In this review, we share the results by state, beginning with the western markets and then concluding with the eastern markets. In total, BDSA estimates that sales across the 15 markets totaled $1.80 billion during November, which was up 4.2% from a year ago due to the large gain in New York Excluding this, which I explain below, sales fell 4.7%. BDSA updated its Illinois numbers after the state changed its way of counting sales recently.
Western Markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In November, year-over-year growth was negative in 4 states. Growth fell sequentially on a per-day basis in none of these states.
Eastern Markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. In November, year-over-year growth ranged from –25.3% in Illinois to +1370.7% in New York, which had its adult-use sales included by BDSA beginning in January but first included a few months ago. Ohio began adult-use in August which has boosted the growth. Note that Florida and Pennsylvania are medical-only markets. Sequential growth was flat in most markets and negative in one market. The annual growth was negative in several markets and up sharply in two states. We have been warning about Florida potentially slowing despite the strong growth in dispensaries and in unit volumes due to competitive pressure, and it has declined now for three months this year.
For readers interested in a deeper look at cannabis markets across these fifteen states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.
